UFP Technologies, Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
UFP Technologies, Inc. (UFPT) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $167.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2021-11-05
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-09-30 was $167.00K, a 178.33% increase year-over-year.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-06-30 was $200.00K, a 2.44% decline year-over-year.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-03-31 was $242.00K, a 30.46% decline year-over-year.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2020-09-30 was $60.00K.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2018 was $167.00K.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $145.00K, a 59.27% decline from fiscal 2015.
- UFP Technologies, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $356.00K, a 70.80% decline from fiscal 2014.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-09-30 | $167.00K 10-Q · filed 2021-11-05 | $367.00K derived: sum of 2 quarters · filed 2021-11-05 | $608.00K 10-Q · filed 2021-11-05 | |||
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-06 | $441.00K 10-Q · filed 2021-08-06 | ||||
| 2021-03-31 | $242.00K 10-Q · filed 2021-05-07 | |||||
| 2020-09-30 | $60.00K 10-Q · filed 2021-11-05 | $265.00K derived: sum of 2 quarters · filed 2021-11-05 | $612.00K 10-Q · filed 2021-11-05 | $2.30M 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $205.00K 10-Q · filed 2021-08-06 | $553.00K 10-Q · filed 2021-08-06 | ||||
| 2020-03-31 | $348.00K 10-Q · filed 2021-05-07 | |||||
| 2018-12-31 | $167.00K 10-K · filed 2021-03-12 | |||||
| 2018-03-31 | $167.00K 10-Q · filed 2019-11-08 | |||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | |||||
| 2016-12-31 | $145.00K 10-K · filed 2019-03-15 | |||||
| 2015-12-31 | $356.00K 10-K · filed 2018-03-16 | |||||
| 2014-12-31 | $1.22M 10-K · filed 2017-03-10 | |||||
| 2013-12-31 | $818.00K 10-K · filed 2016-03-11 | |||||
| 2012-12-31 | $831.00K 10-K · filed 2015-03-13 | $831.58K 10-K · filed 2013-03-15 | ||||
| 2011-12-31 | $700.00K 10-K · filed 2014-03-14 | $699.66K 10-K · filed 2012-03-15 | ||||
| 2010-12-31 | $854.01K 10-K · filed 2013-03-15 | |||||
| 2009-12-31 | $23.42K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |